H
Honglan Li
Researcher at Janssen Pharmaceutica
Publications - 2
Citations - 287
Honglan Li is an academic researcher from Janssen Pharmaceutica. The author has contributed to research in topics: Randomized controlled trial & Placebo. The author has an hindex of 2, co-authored 2 publications receiving 162 citations.
Papers
More filters
Journal ArticleDOI
Efficacy of Esketamine Nasal Spray Plus Oral Antidepressant Treatment for Relapse Prevention in Patients With Treatment-Resistant Depression: A Randomized Clinical Trial.
Ella Daly,Madhukar H. Trivedi,Adam Janik,Honglan Li,Yun Zhang,Xiang Li,Rosanne Lane,Pilar Lim,Anna R. Duca,David Hough,Michael E. Thase,John Zajecka,Andrew Winokur,Ilona Divacka,Andrea Fagiolini,Wiesław Jerzy Cubała,István Bitter,Pierre Blier,Richard C. Shelton,Patricio Molero,Husseini K. Manji,Wayne C. Drevets,Jaskaran Singh +22 more
TL;DR: Continuation of esketamine nasal spray in addition to oral antidepressant treatment resulted in clinically meaningful superiority in delaying relapse compared with antidepressant plus placebo in patients with TRD in stable remission.
Patent
Esketamine for the treatment of depression
Carla M. Canuso,Ella Daly,Wayne C. Drevets,Honglan Li,David Hough,Adam Janik,Rachel Ochs-Ross,Jaskaran Singh,Ewa Wajs,Peter Zannikos +9 more
TL;DR: The present invention provides methods of maintaining stable remission or stable response achieved by a patient with depression following administration of a therapeutically effective amount of esketamine during an initial administration phase.